Transition Bio Limited

Transition Bio Ltd from Cambridge UK is a small, active company founded four years ago. With 30 employees and £1,326,560 in assets, it operates from a real address and is overseen by four directors and one owner. The company regularly imports optical and medical tools and devices, with 23 months of import activity recorded, the latest in February 2025.

The company’s website, Transition Bio, describes itself as operating in the research and experimental development on biotechnology industries. While no e-commerce functionality is apparent, the site suggests a focus on scientific innovation and collaboration. It’s a tight-knit operation, with a clear emphasis on biotechnology research.

Financially, Transition Bio Ltd presents a mixed picture. Current assets have decreased by 20% to £1,900,000, while net assets have plummeted 89% to -£11,000,000. Bank borrowings have surged by 2,400%, reaching £29,000, and cash reserves fell 30% to £420,000. Creditors decreased by 18%, suggesting better debt management. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) helps it stay agile, but the sharp equity drop raises questions. With no auditor mentioned (likely exempt as a small company), the figures rely on unaudited statements.

The significant increase in liabilities, particularly bank borrowings, suggests the company is burning through cash, possibly to fund research and development. The decrease in assets and the large net loss indicate financial strain, though it’s common for biotechnology startups to operate at a loss while pursuing scientific breakthroughs. The ownership structure, with a single owner, may also influence decision-making and access to funding.

Registered in England/Wales under the registration number 12747523, with a registered address at CB2 8DU, United Kingdom, Cambridge, Cambridgeshire, Eastbrook, Shaftesbury Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.